In vitro proliferation and differentiation of megakaryocytic progenitors in patients with aplastic anaemia, paroxysmal nocturnal haemoglobinuria and the myelodysplastic syndromes.

被引：0
|
作者：
Cox, CV [1 ]
Killick, S [1 ]
Elebute, MO [1 ]
Marsh, JCW [1 ]
Gordan-Smith, EC [1 ]
Gibson, FM [1 ]
机构：
[1] St George Hosp, Sch Med, Dept Haematol, London SW17 0RE, England
来源：
EXPERIMENTAL HEMATOLOGY | 1999年 / 27卷 / 07期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
323
引用
收藏
页码：122 / 122
页数：1
相关论文
共 50 条
  • [31] Recurrent acute myocardial and renal infarction with aplastic anaemia/paroxysmal nocturnal haemoglobinuria syndrome: a case report
    Kato, Yuta
    Hadase, Mitsuyoshi
    Nakamura, Takashi
    EUROPEAN HEART JOURNAL-CASE REPORTS, 2024, 8 (10)
  • [32] Paroxysmal nocturnal haemoglobinuria phenotype cells and leucocyte subset telomere length in childhood acquired aplastic anaemia
    Tutelman, Perri R.
    Aubert, Geraldine
    Milner, Ruth A.
    Dalal, Bakul I.
    Schultz, Kirk R.
    Deyell, Rebecca J.
    BRITISH JOURNAL OF HAEMATOLOGY, 2014, 164 (05) : 717 - 721
  • [33] Relationship between immunological abnormalities and paroxysmal nocturnal haemoglobinuria-associated clones in myelodysplastic syndromes
    Okamoto, T
    Okada, M
    Takatsuka, H
    Wada, H
    Fujimori, Y
    Kakishita, E
    BRITISH JOURNAL OF HAEMATOLOGY, 2001, 114 (03) : 731 - 733
  • [34] Evaluation of cellular proliferation markers in patients with myelodysplastic syndromes.
    Ismail, SO
    Mutema, G
    Perrotta, G
    Hornback, B
    Wibowo, A
    Mazzella, F
    KowalVern, A
    Schumacher, HR
    BLOOD, 1997, 90 (10) : 4040 - 4040
  • [35] Eculizumab, a terminal complement inhibitor, improves anaemia in patients with paroxysmal nocturnal haemoglobinuria
    Schubert, Joerg
    Hillmen, Peter
    Roeth, Alexander
    Young, Neal S.
    Elebute, Modupe O.
    Szer, Jeffery
    Gianfaldoni, Giacomo
    Socie, Gerard
    Browne, Paul
    Geller, Robert
    Rother, Russel P.
    Muus, Petra
    BRITISH JOURNAL OF HAEMATOLOGY, 2008, 142 (02) : 263 - 272
  • [36] Adverse transfusion reactions in patients with aplastic anaemia or myelodysplastic syndromes
    Moncharmont, Pierre
    Quittancon, Elodie
    Barday, Gregory
    Benamara, Abdelhalim
    VOX SANGUINIS, 2019, 114 (04) : 349 - 354
  • [37] In vitro proliferation and differentiation of erythroid progenitors from patients with myelodysplastic syndromes: evidence for Fas-dependent apoptosis
    Claessens, YE
    Bouscary, D
    Dupont, JM
    Picard, F
    Melle, J
    Gisselbrecht, S
    Lacombe, C
    Dreyfus, F
    Mayeux, P
    Fontenay-Roupie, M
    BLOOD, 2002, 99 (05) : 1594 - 1601
  • [38] Survey of outcomes of unrelated cord blood transplant in patients with severe acquired aplastic anaemia and paroxysmal nocturnal haemoglobinuria. A study by EUROCORD and the Aplastic Anaemia Working party of the EBMT
    Ruggeri, A.
    de latour, R. Peffault
    Michel, G.
    Gandemer, V.
    Sanz, G. F.
    Ionescu, I.
    Purtill, D.
    Boudjedir, K.
    Nabhan, S.
    Gluckman, E.
    Socie, G.
    Passweg, J.
    Rocha, V.
    BONE MARROW TRANSPLANTATION, 2009, 43 : S55 - S55
  • [39] Recurrent life-threatening reactions to platelet transfusion in an aplastic anaemia patient with a paroxysmal nocturnal haemoglobinuria clone
    Mohamed, M.
    Bates, G.
    Richardson, D.
    Burrows, L.
    INTERNAL MEDICINE JOURNAL, 2014, 44 (09) : 925 - 927
  • [40] Impaired migration in vitro of neutrophils from patients with paroxysmal nocturnal haemoglobinuria
    Pedersen, TL
    Yong, K
    Pedersen, JO
    Hansen, NE
    Dano, K
    Plesner, T
    BRITISH JOURNAL OF HAEMATOLOGY, 1996, 95 (01) : 45 - 51
12345